Drug Profile
Research programme: brain cancer stem cell therapeutics - Loma/Palisade Bio
Alternative Names: HNSC - Palisade Bio; NSI 566 - Loma/Palisade Bio; NSI-566 - GlioblastomaLatest Information Update: 29 Apr 2021
Price :
$50
*
At a glance
- Originator Neuralstem
- Developer Loma Linda University Medical Center; Neuralstem
- Class Stem cell therapies
- Mechanism of Action Angiogenesis inhibitors; Cell death stimulants; Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Glioblastoma